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Abstract The substitution of large spectrum antibiotics for
natural bioactive molecules (especially polyphenolics) for the
treatment of wound infections has come into prominence in the
pharmaceutical industry. However, the use of such molecules
depends on their stability during environmental stress and on
their ability to reach the action site without losing biological
properties. The application of cyclodextrins as a vehicle for
polyphenolics protection has been documented and appears to
enhance the properties of bioactive molecules. Therefore, the
encapsulation of gallic acid, an antibacterial agent with low
stability, by b-cyclodextrin, (2-hydroxy) propyl-b-cyclodex-
trin and methyl-b-cyclodextrin, was investigated. Encapsula-
tion by b-cyclodextrin was confirmed for pH 3 and 5, with
similar stability parameters. The (2-hydroxy) propyl-b-cyclo-
dextrin and methyl-b-cyclodextrin interactions with gallic acid
were only confirmed at pH 3. Among the three cyclodextrins,
better gallic acid encapsulation were observed for (2-hydroxy)
propyl-b-cyclodextrin, followed by b-cyclodextrin and
methyl-b-cyclodextrin. The effect of cyclodextrin encapsula-
tion on the gallic acid antibacterial activity was also analysed.
The antibacterial activity of the inclusion complexes was
investigated here for the first time. According to the results,
encapsulation of gallic acid by (2-hydroxy) propyl-b-cyclo-
dextrin seems to be a viable option for the treatment of skin and
soft tissue infections, since this inclusion complex has good
stability and antibacterial activity.
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Introduction
In the last years, the application of cyclodextrins (CDs) as
functional carriers in the pharmaceutical industry has
increased. CDs are cyclic oligosaccharides having the
molecular shape of a truncated cone and containing
hydroxyl groups oriented to the outer molecular surface
and hydrophobic groups aligned along the interior of the
cavity. This creates an micro-heterogeneous environment
which allow the formation of inclusion complexes (IC)
with a wide range of molecules, from straight or branch
aliphatic chains to polar compounds, thus changing the
chemical, physical or biological properties of the included
guests [1, 2].
The IC stability is extremely dependent on the 3D fit
between the CDs’ cavity and the guest molecule and on the
specific local interactions between the CDs’ surface groups
and the ‘‘guest’’ [3]. Complex stability relies on hydro-
phobic forces, hydrogen bonds, van der Waals interactions,
and on other factors, like the release of a ring strain and
modifications in solvent surface tension. The combinations
of these factors render the IC to a more stable energetic
state [4, 5]. Thermodynamic factors, like enthalpy (DH),
entropy (DS) and Gibbs free energy (DG), can be used as
parameters to describe the complexation process, since the
temperature influences the selectivity of the interaction
between CD and the bioactive molecule [6]. In the case of
organic compounds as ‘‘guest’’ molecules, additional fac-
tors such as pH and solvents seem to play a major role for
IC formation [7].
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The a, b and c CDs, differing in the cavity volume and
diameter, are most used for pharmacological applications
with most industrial applications involving bCD due to the
capacity of this compound to encapsulate a wide range of
molecules. This native CD has been subjected to a variety
of chemical modifications in order to enhance the physi-
cochemical properties [7]. For instance, (2-hydroxy) pro-
pyl-b-cyclodextrin (HPbCD) and methyl-b-cyclodextrin
(MbCD) are more hydrophilic than bCD itself. Moreover,
these derivatives possess higher solubility than the bCD
(500 and 750 g L-1 at room temperature compared to
18 g L-1 for bCD), which increases the complexation of
poorly water soluble molecules [8].
Wound infection has been one of the major causes of
the delayed on the healing process or scar development.
These infections, often associated to Staphylococcus and
Klebsiella species, may range from superficial infections
to life-threatening ones in compromised patients. Broad-
spectrum antibiotics have been indiscriminately used for
the treatment of skin and soft tissue infections, changing
the normal skin flora, and leading to multi-resistant
strains [9]. Therefore, the demand for new antibacterial
agents has increased in recent years, and polyphenolics
are a major group of compounds used for that propose
[7].
Gallic acid, also known as 3,4,5-trihydroxybenzoic acid,
is a simple phenolic acid frequently found in plants with
several biological activities. For instance, gallic acid has
been described as antioxidant, anti-inflammatory, anticar-
cinogenic and antimicrobial [10–13]. Nevertheless, gallic
acid, as other polyphenolics, has reduced pharmacological
applicability due to its low water solubility [14, 15] and
sensitivity to environmental stress (pH, light, temperature),
factors that cause poor bioavailability [16–18].Thus, to
maintain the gallic structural integrity and allow it to reach
the physiological targets without losing any activity, an
encapsulation device is necessary.
Encapsulation of phenolic acids by CDs has been
reported by several authors, with native CDs being mostly
used, in this context and hydroxycinnamic acids (caffeic,
chlorogenic and rosmarinic acid) as guests [8, 19–22]. For
these compounds IC formation with a 1:1 stoichiometry is
generally reported, with the phenolic orientation within the
CD depending on the structure of the guest as well as the
IC stability. Moreover, the application of CD derivatives
(HPbCD and MbCD) was reported by C¸elik et al. [8]. The
corresponding IC with rosmaniric acid have higher stability
than the one of native CD, suggesting that the substituents
facilitate encapsulation [8].
Therefore, this work aims at evaluating the effect of pH
on the stability of the IC formation between gallic acid and
three CDs (bCD, HPbCD and MbCD). Additionally, the
influence of gallic acids encapsulation on its antibacterial
activity was assessed for the first time.
Materials and methods
Material
Gallic acid (3,4,5-trihydroxybenzoic acid) was purchased
from Merck, b-cyclodextrin (bCD, 1135 g mol-1) and (2-
hydroxy) propyl-b-cyclodextrin (HPbCD, 1309 g mol-1,
MS & 0.6) were acquired from AppliChem, and methyl-b-
cyclodextrin (MbCD, 1310 g mol-1, MS & 1.6) was
obtained from Wacker. Gallic acid stock solution (2 or
10 mM) was prepared in methanol (MeOH) and kept for
30 min in an ultrasonic bath. Stock solutions for each CD
(4 9 10-2 M) were prepared in distilled water. The bCD
solution was maintained at 50 C and 200 rpm in order to
improve its solubility in water.
Buffer and pH effect
Gallic acid solutions (1 9 10-5 M, 2 % MeOH) were
prepared in two different buffers (H3PO4/NaOH and
KH2PO4/K2HPO4) at pH 3, 5, 7, and 8. The buffers were
prepared as follows: the desired pH (3, 5, 7, and 8) was
achieved by mixing proper amounts of H3PO4
(1 9 10-2 M, pH 2.05) and NaOH (1 M, pH 14) for
H3PO4/NaOH buffer and K2HPO4 (5 9 10
-3 M, pH 8.02)
and KH2PO4 (5 9 10
-2 M, pH 2.89) for the buffer KH2-
PO4/K2HPO4. The solutions were maintained for 30 min in
an ultrasonic bath to insure the total solubilisation of gallic
acid. The UV–Vis absorbance spectrum of gallic acid was
recorded between 200 and 360 nm for each condition.
Inclusion complex preparation
In order to determine the stoichiometry and stability con-
stants of the ICs between gallic acid and the three CDs,
solutions with different concentrations of each CD
(between 0 and 6 9 10-3 M) were added to a gallic acid
solution (1 9 10-5 M) for each pH (buffer H3PO4/NaOH).
The solutions were kept for 30 min in an ultrasonic bath.
Afterwards they were maintained 24 h at 25 C and 50 rpm
in the dark. Samples of each solution were taken for
absorbance measurements.
The absorbance of the solutions of gallic acid or the
corresponding ICs was measured at kmax (259 nm for pH 3
or 261 nm for pH 5). The gallic acid concentration was
calculated based on the previously determined calibration
curve. The CDs had no influence on the gallic acid spectra
taking into account the conditions used.
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All absorption measurements were recorded on a Jasco
V560 spectrometer using a 1 cm quartz cuvette.
Stoichiometry, stability constant and thermodynamic
parameters calculation
The stoichiometry and stability constant (K) of each com-
plex at the different pH were assessed based on the mod-
ified Benesi-Hildebrand equation [23] (Eqs. 1, 2), where
[CD]0 is the CD initial concentration, A is the absorbance
intensities in the presence of CD, A0 is the absorbance
intensities without CD, and A0 is the limiting intensity of
absorption. The equations were used to define the IC
stoichiometry: Eq. (1) represents a 1:1 complex and the
Eq. (2) 1:2 complex. K was obtained from the slope of the
graph.
1
A  A0 ¼
1
A0  A0 þ
1
KðA0  A0ÞCD0 ð1Þ
1
A  A0 ¼
1
A0  A0 þ
1
KðA0  A0ÞCD20
ð2Þ
A double reciprocal Benesi-Heldebrand plot was drawn
using both equations, i.e. 1
AA0 vs
1
½CD
 
or 1
AA0 vs
1
½CD2
 
.
The better fit (higher r2) of the Benesi-Hildebrand plots
was used to identify the stoichiometry of the ICs. The DG
was calculated using K and Eq. 3, where R is the gas
constant, and T the temperature.
DG ¼ RTlnðKÞ ð3Þ
Bacterial susceptibility to gallic acid IC
Bacterial suspension
The antibacterial activities of gallic acid in buffered
aqueous H3PO4/NaOH (selected buffer) at different pH
values as well as the activity of the ICs, were tested against
the bacteria Staphylococcus epidermidis (S. epidermidis,
ATCC 12228), Staphylococcus aureus (S. aureus, ATCC
6538) and Klebsiella pneumoniae (K. pneumoniae, ATCC
11296). The bacteria were grown in tryptic soy agar (TSA,
Merck, Germany) for 24 h at 37 C. The cells were inoc-
ulated in tryptic soy broth (TSB, Merck, Germany) and
incubated for 18 h at 37 C under agitation (120 rpm).
Subsequently, bacterial concentration of each strain was
adjusted to 1 9 106 cells mL-1 via absorbance readings
and determined with the corresponding calibration curve.
Susceptibility assay of gallic acid
The minimal bactericidal concentration (MBC) was
obtained according to the method described by Wiegand
[24], an adaptation of the standard methods published by
Clinical and Laboratory Standards Institute (CLSI) and the
European Committee on Antimicrobial Susceptibility
Testing (EUCAST, 2000), using the broth micro dilution
procedure. Thus, stock solutions of 3.74 9 10-3 M of
gallic acid were prepared at pH 3, 5, 7, and 8 (aqueous
H3PO4/NaOH buffer). Serial dilutions of these solutions
were made with MHB (Mueller–Hinton broth, Merck,
Germany) to a final volume of 50 lL. Afterwards, 50 lL of
each bacterium suspension were added to give a final
concentration of 5 9 105 cell mL-1. Gallic acid- and
bacteria-free controls were also included. The plates were
incubated for 24 h at 37 C. The number of viable cells
was assessed by determination of the number of colony
forming units (CFUs), by plating 10 lL of cell suspension
from each well onto TSA, and incubated for 24 h at 37 C.
The procedure was made in triplicate for each pH and
bacterium combinations in at least three independent
measurements.
Antibacterial activity of ICs
The ICs capacity to destroy the bacteria was also measured
quantitatively. A volume of 50 lL of each complex (IC
bCD/gallic acid and IC HPbCD/gallic acid) was added to
50 lL of 1 9 10-6 cells mL-1 of each bacterium, on a 96
well plate. Bacteria and medium controls were also inclu-
ded. The plates were incubated for 24 h at 37 C. The
antimicrobial activity of each solution was assessed by
determination of the number of CFUs as described above.
The procedure was performed in triplicate for each bacte-
rium at least in three independent assays. Solutions of
buffer, gallic acid (1 mM), bCD (1 mM) and HPbCD
(1 mM) were also included to ensure that none of these
factors alone could influence on the antibacterial activity of
the ICs.
All mathematical analyses were carried out using the
Origin Pro software.
Results and discussion
The biological properties of gallic acid remain active even
at low concentrations [18], however this phenolic acid is
quite susceptible to degradation under environmental stress
(pH, temperature, light and oxygen) [25]. Therefore, the
gallic acid protection by encapsulation by CDs was studied.
Influence of buffer and pH on the gallic acid properties
The UV–Vis spectra of polyphenols reflect alterations of
the electronic energy levels within the molecules, caused
by electronic transitions between p-type molecular orbitals
[26, 27]. The nature of the solvent, steric effects, formation
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of resonance forms, intra- and inter-molecular hydrogen-
bonding, electron-donating and electron-withdrawing sub-
stituents on the benzene ring are factors responsible by
alterations on polyphenols spectra [25].
Therefore, the influence of two different buffers on the
UV–Vis spectra of gallic acid was analysed as well as the
effect of the pH for each buffer (Fig. 1).
The gallic acid UV–Vis spectra usually shows two
bands between 200 and 360, a b-band (lower wavelength)
near 220 nm and a c-band (higher wavelength) near
270 nm. The buffer effect on the gallic acid spectra was
notorious. The intensity of the two peaks, regardless of the
pH, was lower when the phenolic was dissolved in the
KH2PO4/K2HPO4 buffer (Fig. 1a). At pH 8 the peaks were
not distinct, which may be the result of a higher oxidation
state of the gallic acid related to it unstable nature in basic
environments particular notorious in this buffer [25, 28].
The H3PO4/NaOH buffer allowed higher intensity of the
characteristic peaks and the changes caused by pH were
also more evident. The gallic acid spectra profile was the
same for the pH range tested. However, an increase of pH
induced a blue shift (a shift of kmax towards shorter
wavelengths) for both bands being more notorious for the
c-band (273 nm for pH 3, 261 nm for pH 5, 258 nm for pH
7, and 258 nm for pH 8) and also an increase of intensity
(hyperchromic effect). The H3PO4/NaOH buffer was cho-
sen for further work, since the effect of pH on the gallic
acid UV–Vis spectra was more obvious when it was used.
As mentioned above, the pH is strongly linked to the
stability of the polyphenols and affects their UV–Vis
spectra [25]. Gallic acid has two ionisable moieties: (i) the
carboxylic group and (ii) the hydroxyl groups attached to
the phenolic ring (Fig. 2). The pH affects the ionization
state of gallic acid. The phenolic acid is neutral (Fig. 2a) at
acid pH (\4.4), contains a deprotonated carboxylate group
between 4.5 and 7, and at basic pH will be deprotonated at
both the carboxylic acid and hydroxyl groups [28, 29]. The
gallic acid ionisation states with increasing pH have been
attributed to the three hydroxyl groups (Fig. 2). The for-
mation of unstable quinones intermediates and other reso-
nance forms has been linked to the reduction of intensity of
the c-band as the pH increases (Fig. 1) [25]. Moreover, for
basic pH ([7) gallic acid has been described as unstable,
suffering fast autoxidation which result on the formation of
degradation products [25, 28]. The presence of these pro-
ducts may explain the changes observed in the spectra at
pH 8 in both buffers.
The pH-dependent antibacterial activity of gallic acid
has been attributed to the ability to exchange protons with
the bacteria and the environment. The antibacterial mech-
anism of gallic acid relies on its affinity to the lipophilic
membrane layer, which enable the gallic acid transport and,
consequently, cytoplasm acidification causing protein
denaturation. The acidification of cell environment causes
variations on the potassium ions efflux, alters the electrical
potential of the cell and improves its permeability. This
cascade of events leads to irreversible alterations on the
cell and, consequently, to its death [30, 31].
Fig. 1 UV–Vis spectra of gallic acid (1 9 10-5 M) dissolved in KH2PO4/K2HPO4 (a) and H3PO4/NaOH (b) buffer at pH 3 (black), pH 5 (red),
pH 7 (blue), and pH 8 (green). (Color figure online)
Fig. 2 Chemical structures of neutral gallic acid (a) and the gallic
acid carboxylate anion (b)
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In addition, the skin and soft tissues infections result from
the colonization and proliferation of complex poly-microbial
communities. The infections may be triggered by natural
microflora such as Staphylococcus, Micrococcus and Cory-
nebacterium sp. or by not typical resident microflora gram
negative bacteria (Klebesiella, Capnocytophaga, Barton-
ella). The proliferation of pathogenic bacteria on the wound
site has been related to the pH of the surrounding environ-
ment [32, 33]. Since the wound infection microflora depends
on the environmental pH as well as the gallic acid biological
properties [25], the gallic acid antibacterial activity at dif-
ferent pH was analysed (Table 1). Three bacteria usually
isolated from infected wound, two gram positive (S. epide-
rmidis and S. aureus) and one gram negative (K. pneumo-
niae) were used [34].
Regarding the gram positive bacteria, the pH had no
influence on the MBC obtained for S. aureus (0.47 mM)
and MBC for S. epidermidis was 0.47 mM, at pH 3 and
0.24 mM for higher pH. In fact, it was described that S.
epidermids growth is enhanced by acid environments [33].
Thus, the lower susceptibility of this bacterium at pH 3
may result from higher metabolic activity. These results
suggest that all forms of gallic acid (neutral and anionic)
are active against gram positive bacteria under the condi-
tions tested. A relation between pH and K. pneumoniae’s
susceptibility to gallic acid was observed, the MBC
obtained decrease with pH basification.
The optimal growth pH for this gram negative bacterium
is located near 5 and 6 [35], the pH used to access the
bacterial susceptibility exceeded that pH range. Bacteria
cells have mechanisms responsible for controlling the pH
variation between the environment and the cytoplasm. The
maintenance of optimal cytoplasmic pH comprises a
combination of strategies, such as cytoplasm buffering,
adaptations on the membrane structure, active ion trans-
portation and metabolic consumption of acids and bases
[36]. However, in specific situations the pH homeostasis
mechanisms can fail, leading to significant changes on the
pH variation thus decreasing the cell metabolism. Such
situations may occur when the cell increases the uptake of
weak acids to equilibrate the difference between external
and internal pH. The weak acids can freely be transported
through the bacteria membrane therefore causing protons
release and consequent cytoplasm acidification [37].
In this assay, the addition of buffers, with different pH,
to the culture medium has triggered these pH homeostasis
mechanisms. Thus, the pH-dependent MBC obtained for K.
pneumoniae may be a consequence of rising uptake of
gallic acid (weak acid) to keep the pH homeostasis, which
resulted in the accumulation of the organic acid on the
cytoplasm, hyperacidification and, ultimately, cell death
[37].
Impact of pH on the gallic acid/bCD interaction
The gallic acid c-band (near 270 nm) was selected for the
analysis of the interactions with CD since it is the most used
for its characterization (HSDB—Hazardous Substances
Data Bank). Figure 3 displays the effect of bCD concentra-
tion and pH on gallic acid UV–Vis absorbance spectra,
collected after 24 h of complexation. Regardless of the pH,
as the CD concentration increases the kmax intensity of gallic
acid decreases. At higher pH (7 and 8) the alterations caused
by bCD on the phenolic spectra were subtle, just a slight
absorbance variation was detected (Fig. 3). The reduction of
pH highlight the effects of CD on the gallic acid spectra. At
pH 3 and 5, the spectra show an isosbestic point near 225 nm
and an hypsochromic effect (the kmax shift to lower wave-
length). The isosbestic point indicates the presence of gallic
acid in free and encapsulated form. The hypochromic effect
observed as CD concentration increase may indicate that
gallic acid is totally embedded in the CD’s cavity [19]. Both
effects support the IC formation between bCD and gallic
acid in this pH range and the notion that the groups involved
in the complexation process are located near the chromo-
phore [19]. Other authors observed similar effects of bCD on
gallic acid spectra [15, 18, 29]; they also confirmed the
encapsulation by SEM (scanning electron microscope),
where the free gallic acid morphology was not detected after
molecular inclusion [18].
As referred above, no significant effects were observed
on the gallic acid UV–Vis spectra at pH 7 and 8 (Fig. 3)
probably due to the absence of ICs or their lower stability.
Thus, complex formation was only characterized at pH 3
and 5.
The UV–Vis absorbance spectra confirmed IC formation
between gallic acid and bCD. However, the binding
strength and the effects caused by complexation on the
guest properties deserved further analysis. Therefore,
complex stoichiometry and stability in terms of K and DG
of the ICs were evaluated [38]. The stoichiometry and
K were determined UV–Vis spectroscopically by using the
Benesi-Hildebrand equation (Eq. 1) and DG was deter-
mined based on Eq. 3.
Table 1 Minimal bactericidal concentration of gallic acid dissolved
on H3PO4/NaOH (pH 3, 5, 7 and 8) against K. pneumoniae, S. epi-
dermidis and S. aureus (5 9 10-5 cell mL-1)
MBC (mM) K. pneunmoniae S. epidermidis S. aureus
pH3 0.47 0.47 0.47
pH5 0.23 0.23 0.47
pH7 0.23 0.23 0.47
pH8 0.12 0.23 0.47
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A linear relation (Fig. 4) was obtained for the two pH
values (3 and 5), indicating that 1:1 complexes between
gallic acid and bCD are formed.
The pH range analysed (3 and 5) had low influence on
K and DG, and the values obtained were similar (Table 2).
The highest values were obtained for pH 5, however with
r2 = 0.865. At pH 3, the linear relationship obtained was
better (r2 = 0.957) but the K and DG were lower. The ICs
formed at pH 3 or 5 were formed spontaneously by an
exergonic reaction (DG \ 0) [39]. IC formation involves
the replacement of polar water molecules from the hydro-
phobic CD cavity by gallic acid. The gallic acid neutral
species (pK = 4.4) at acid environment [28] may enhance
the encapsulation process. Since K and DG were similar at
both pH values, pH 3 was considered as the best condition
for gallic acid complexation by bCD due to the higher r2.
According to the author’s knowledge, there are just few
publications regarding the interaction of gallic acid with
bCD [15, 18, 29]. These papers obtained similar thermo-
dynamic parameters for the ICs and also described ana-
logues mechanisms of encapsulation. They all stated that
the gallic acid is completely encapsulated within the bCD
cavity with the carboxylic group oriented towards the small
CD opening and the three hydroxyl groups placed near the
Fig. 3 UV–Vis spectra of gallic acid (1 9 10-5 M) at different b-cyclodextrin concentrations (0–6 9 10-3 M) at pH 3, 5, 7 and 8 (aqueous
H3PO4/NaOH buffer)
Fig. 4 Benesi-Hildebrand plot for the gallic acid complexation with
bCD, at pH 3 and 5 (buffer H3PO4/NaOH)
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wider entrance (Fig. 5). Here we show that the major
interaction between gallic acid and bCD is presumably
hydrophobic, since the bCD is not charged at the pH range
used for the measurements. Thus, the ICs stability is due to
hydrophobic interactions between gallic acid and the cavity
as well as by hydrogen bonds established between the
gallic acid and the CD hydroxyl groups [18, 29]. Thus, the
gallic acid neutral species (pH 3) may be capable of deeper
insertion into the CD cavity than the ionized form
(pH [ 4.4) (Fig. 5). This fact explains the lower stability
observed for the IC formed at pH 5 and the lack of
encapsulation at higher pH. Based on our results and on
those of published work, the stability of the IC between
bCD and gallic acid may be enhanced in the acid envi-
ronment (pH \4.4).
Gallic acid encapsulation by HPbCD and MbCD
The encapsulation of polyphenolics by modified CDs has
been described as leading to more stable complexes than
the ones obtained with native CDs [8, 40]. Two bCD
derivatives (HPbCD or MbCD) were chosen to test this
assumption based on their improved solubility and also
because their substituents enlarged the cavity opening
reducing the intramolecular hydrogen bond network. These
properties could facilitate the incorporation of the guest
molecule (in this case gallic acid) to the cavity, leading to
the formation of a complex with higher stability. To the
best of our knowledge, the inclusion of gallic acid by
HPbCD or MbCD is analysed for the first time in this
work.
The effect of pH (3, 5, 7, and 8) on the interaction
between gallic acid and HPbCD and MbCD was studied.
Variations on the UV–Vis spectra of the guest induced by
these CDs at pH 5, 7 and 8 were not detected under the
conditions used (data not shown). Since gallic acid
encapsulation with native CD (bCD) was more efficient at
pH 3 this pH value was chosen to study the effect of the
bCD modifications on the complexation with gallic acid
(Fig. 6).
The gallic acid behaviour was similar in the presence of
all three CDs. A correlation between the reduction of gallic
acid concentration in solution with the increase of the CDs
concentration was observed. These values were obtained
from the UV–Vis spectra, where an hypochromic effect
Fig. 5 Schematic representation of location of the gallic acid molecule inside the bCD cavity at different pH values
Fig. 6 Determination of gallic acid concentration (based on the
absorbance measured at the kmax,) after 24 h of complexation with
different concentrations of cyclodextrins (0–6 mM) at pH 3 (aqueous
H3PO4/NaOH buffer)
Table 2 IC bCD/gallic acid
characterization parameter at
pH 3 and pH 5
pH 3 pH 5
Stoichiometry 1:1 1:1
K (M-1) 41 71
DG (kJ) -9.83 -10.4
r2 0.953 0.865
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(reduction of kmax intensity) was observed with the
increase of CDs concentration. This effect may result from
the interference with molecular groups responsible for the
UV–Vis absorbance induced by encapsulation [19]. The
same behaviour has already been mentioned above for the
native CD.
Figure 6 suggests that the IC formed by the three CDs
behave similarly, but characterization (stoichiometry,
K and DG) of the complexes revealed differences. The ICs
obtained for the substituted CDs (HPbCD/gallic acid and
MbCD/gallic acid) have 1:1 stoichiometry, which is con-
sistent with the result obtained for native CD. Nevertheless,
the stability and thermodynamic parameters are different
for these two CDs (Table 3). The HPbCD has a higher
K than the bCD complex and, as a consequence, a lower
DG. Thus, stability of the complex between HPbCD and
gallic acid is higher in comparison to the complex of native
CD. As the size of the molecular cavity of HPbCD is
similar to the one of bCD (7 glucopyranose units) the
higher K obtained for the HPbCD suggest that the
hydroxypropyl groups play a role on the IC process. These
groups seem to stabilize the gallic acid molecules trapped
inside the cavity [41]. The opposite was observed for the
MbCD, since a lower stability of the IC was observed
(Table 3). This CD is therefore less suited for the com-
plexation of gallic acid when compared to native CD or
HPbCD.
Based on the results presented above, and as expected,
the pH played a major role in the encapsulation of gallic
acid by CDs. At pH 3, IC formation with the three CDs is
best, and pH 5 creates suitable conditions for the com-
plexation between gallic acid and native CD, with similar
thermodynamic parameters obtained at pH 3.
Antibacterial efficacy of gallic acid/CD complexes
Encapsulation by CDs usually improves physicochemical
and biological properties of included guest molecules
although Zhao [21] showed that the antioxidant and anti-
bacterial activity of chlorogenic acid is not affected by
encapsulation with bCD. Here, the antibacterial activities
of the ICs between bCD and gallic acid and HPbCD and
gallic acid were assessed by a quantitative method. In order
to ensure that gallic acid is capable of killing all bacteria
cells in an infected wound, the environmental condition
less favourable to its action (pH 3) was used for this ana-
lysis. At this pH, complexation between gallic acid and
bCD or HPbCD is best.
The IC complexes were prepared by using solutions
with the same concentrations (1 mM) of CD and gallic
acid, considering the stoichiometry determined above
(1:1). As expected, the controls (buffer, bCD and HPbCD)
had no influence on the bacteria growth.
Figure 7 displays the susceptibility of the three bacteria
strains used when exposed to the ICs. Both ICs (bCD/gallic
acid and HPbCD/gallic acid) were capable of reducing the
growths of the three bacteria, but their antibacterial activity
was different for the bacteria used. Against the gram
negative bacteria (K. pneumoniae) both ICs displayed the
same effect, namely completely growth inhibition. In the
case of the gram positive bacteria (S. epidermidis and S.
aureus), the antibacterial activity of gallic acid is reduced
upon bCD encapsulation. Still, the number of CFU detec-
ted was less than 4 log when compared with the control.
The other IC (HPbCD/gallic acid) retained the gallic acid
activity against S. epidermis, but allowed the growth of 1
log of S. aureus.
The gram positive and negative bacteria differ in their
cell wall and, consequently, in their susceptibility to anti-
microbial agents. The gram positive bacteria have a con-
tinuous cell wall of a thick layer of peptidoglycan, while
gram negative bacteria have a non-continuous cell enve-
lope formed by a thin layer of peptidoglycan covered by an
Fig. 7 Quantitative analysis of the microbial activity of the ICs
between gallic acid and bCD and gallic acid and HPbCD against K.
pneumonia, S. epidermidis, and S. aureus (5 9 105 cell mL-1). The
inclusion complexes were prepared at pH 3 (aqueous H3PO4/NaOH
buffer) with equiolar amounts of gallic acid and CDs (1 mM)
Table 3 IC HPbCD/gallic acid and MbCD/gallic acid characteriza-
tion parameter at pH 3
HPbCD MbCD
Stoichiometry 1:1 1:1
K (M-1) 90 37
DG (kJ) -11 -8.8
r2 0.909 0.477
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outer membrane. Hence, it is expected that gram negative
bacteria are more susceptible to antimicrobial agents than
gram-positive ones [42]. Therefore, the higher suscepti-
bility of the gram negative bacterium (K. pneumoniae) to
the ICs activity suggest that the ICs are capable of reaching
the cell surface more efficiently and, consequently, with a
higher uptake, when compared to other bacteria.
The reduction on the antibacterial activity of gallic acid
regarding the ICs in contact with the gram positive bacteria
may rely on the phenolic acid’s low availability to interact
with bacterial cells. As mentioned above, the antibacterial
mechanism reported for gallic acid involves the interaction
with the cell surface altering its electrochemical potential,
reducing the membrane integrity, and causing hyperacidi-
fication of the cytoplasm via proton donation thus inter-
fering with crucial metabolic pathways. Assuming that
gallic acid is complete encapsulated in the cyclodextrin
cavity forming a stable complex, proton exchange is
probably lower than the one of free gallic acid. Incorpo-
ration of gallic acid within HPbCD seems to allow a better
interaction with bacteria, since the IC with this CD were
capable of preserving gallic acid activity against two bac-
teria, and the growth of S. aureus obtained was minimal. In
conclusion, the encapsulation of gallic acid by the bCD and
HPbCD may be a viable option for the application as an
antibacterial agent.
Conclusions
The role of the solvent and pH on gallic acid properties was
confirmed in this study. The intensity of phenolic acid
peaks was modified by the buffer. The H3PO4/NaOH buffer
allowed a better detection of the pH effect on the UV–Vis
spectra.
The encapsulation of gallic acid by bCD was studied at
pH 3, 5, 7 and 8 and it was observed that the basic envi-
ronment (pH 7 and 8) was less suitable for encapsulation.
At pH 3 and pH 5, the ICs obtained had similar stability
(similar K and DG values) although the linear relation was
better at the more acidic pH. Regarding the substituted
bCD derivatives, encapsulation was only detected at pH 3.
Therefore, the gallic acid neutral form appears to enhance
its ability to form IC with HPbCD and MbCD. All the
complexes obtained had 1:1 stoichiometry regardless of the
CD, but stability of the IC was higher for HPbCD and
lower for MbCD.
Moreover, the antimicrobial activities of the ICs
between bCD and gallic acid and HPbCD and gallic acid
were also analysed. Phenolic activity was retained by
complexation with the CDs. The IC of HPbCD had better
efficiency against the three bacteria and also exhibited
higher stability. Therefore, complexation of gallic acid by
HPbCD may be a viable option for the improvement of
gallic acid applicability as antibacterial agent for the
treatment of skin and soft tissue infections.
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